# FDA recall D-1139-2023

> **Contract Pharmaceuticals Limited Canada** · Class III · drug recall initiated 2023-08-23.

## Product

Clindamycin Phosphate Topical Solution USP, 1%, 60 mL bottle, Rx only, Manufactured by: Contract Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, Manufactured for: Glasshouse Pharmaceuticals Limited Canada, Mississauga, Ontario, Canada, NDC# 71428-003-60

## Reason for recall

Defective Container: slow leakage under the cap

## Distribution

Nationwide in the USA.

## Key facts

- **Recall number:** D-1139-2023
- **Recalling firm:** Contract Pharmaceuticals Limited Canada
- **Classification:** Class III
- **Product type:** drug
- **Status:** Terminated
- **Initiation date:** 2023-08-23
- **Report date:** 2023-09-06
- **Termination date:** 2025-08-06

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Mississauga, N/A, Canada

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=D-1139-2023

## Citation

> AI Analytics. FDA recall D-1139-2023. Retrieved 2026-06-25 from https://api.ai-analytics.org/recall/D-1139-2023. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*